Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06741631 · ClinicalTrials.gov registry record · NA
MyPEEPS LITE Trial
A NA study of HIV/AIDS, sponsored by Columbia University.
- Recruiting
- Registry status
- NA
- Development phase
- 3,200
- Enrollment target
- 2
- Study locations
NCT06741631: Recruiting NA study of HIV/AIDS, sponsored by Columbia University.
NCT06741631 is a NA study of HIV/AIDS that is actively recruiting participants, run by Columbia University. The registered enrollment target is 3,200 participants, below the 33,128-participant average among 61 other HIV/AIDS trials with a reported enrollment target (90% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06741631, a NA study of HIV/AIDS, is actively recruiting participants, sponsored by Columbia University.
- RECRUITING
- Registry status
- NA
- Development phase
- 3,200 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study will use community-informed advertisements and messages through electronic methods to recruit and retain a large (N=3,200), diverse national sample of high-risk young men who have sex with men (YMSM) and non-binary individuals that are assigned male sex at birth, 16-29 years of age to determine the efficacy of the MyPEEPS Mobile intervention on reduced incident HIV infections in comparison to a standard of care condition and to examine the degree to which reduced incident HIV infections occurs in the context of potential multilevel moderators and conceptual mediators. This is key to advancing HIV prevention among HIV-negative US persons at extremely high-risk for HIV seroconversion.
Primary Outcome
OraQuick In-Home HIV Tests will be shipped to participants at baseline, 6 and 12 months.
Conditions Studied
Interventions
- BEHAVIORAL MyPEEPS Mobile
Study Locations (2)
Illinois
- Ann & Robert H. Lurie Children's Hospital of Chicago - Chicago
New York
- Columbia University - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,200 participants |
| Start Date | 2025-01-10 |
| Est. Completion | 2028-12-01 |
| Phase | NA |
What NCT06741631 shows while recruiting
NCT06741631 is an interventional study that assigns participants to a tested intervention. Its 3,200 participants enrollment target places it among the larger protocols in the corpus, below the 33,128-participant average among 61 other HIV/AIDS trials with a reported enrollment target (90% lower).
The record links to 1 condition, with HIV/AIDS appearing as the primary indexed condition, and to 1 intervention - of which MyPEEPS Mobile is the first listed.
NCT06741631 reports a single indexed study location in Illinois, New York.
Frequently Asked Questions
What is clinical trial NCT06741631 about?
NCT06741631 is a clinical study titled "MyPEEPS LITE Trial". This study will use community-informed advertisements and messages through electronic methods to recruit and retain a large (N=3,200), diverse national sample of high-risk young men who have sex with men (YMSM) and non-binary individuals that are assigned male sex at birth, 16-29 years of age to det...
What is the current status of trial NCT06741631?
This trial is currently recruiting. It is a NA study. The enrollment target is 3,200 participants. The study started on 2025-01-10. Estimated completion is 2028-12-01.
What conditions does trial NCT06741631 study?
This clinical trial studies the following conditions: HIV/AIDS.
What interventions are being tested in trial NCT06741631?
The interventions under investigation include: MyPEEPS Mobile (BEHAVIORAL).
Who is sponsoring clinical trial NCT06741631?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06741631 being conducted?
This trial has 2 study locations across Illinois, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV/AIDS
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06741631's enrollment target sits among peer trials
3,200 3rd of 61 higher than 59 of 61 other HIV/AIDS trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV/AIDS trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Mobile Gaming App to Improve Adherence to PrEP
RECRUITING · NA
-
LinkPositively+ A Mobile Health App Delivered Intervention to Improve HIV Care Outcomes Among Black Women Affected by Mental Health and Violence
RECRUITING · NA
-
MyPEEPS Mobile Plus: A Multi-Level HIV Prevention Intervention for Young MSM
RECRUITING · NA
-
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
RECRUITING · NA
-
Improving the Organizational Social Context to Address Structural Racism and Discrimination
RECRUITING · NA
-
Community Health Workers And MHealth to ImProve Viral Suppression Plus (CHAMPS+)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02043457 · 3,200 participants
Identification of Phenotypic Factors That Predict Success for Weight Loss and Long-term Weight Maintenance
- NCT04045665 · 3,200 participants · Phase 3
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
- NCT05381766 · 3,200 participants · NA
Building Access to Food Through Systems and Solidarity
- NCT06042543 · 3,200 participants · NA
Novel, One Stop, Affordable, Point of Care and AI Supported System of Screening, Triage and Treatment Selection for Cervical Cancer in LMICs
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI